Skip to main content
. 2011 May 17;7(2):278–286. doi: 10.5114/aoms.2011.22079

Table III.

Top 10 Charlson and Elixhauser comorbidities associated with biggest increases in transplant procedure length of stay and Medicare payments

Charlson comorbidity % Increase in LOS vs. reference Charlson comorbidity Increase in Medicare payments vs. reference ($)
15 – Moderate or severe liver disease 16.42 (4.80 vs. 29.33) 15 – Moderate or severe liver disease 2,928.03 (-2,203.17 vs. 8,059.23)
8 – Peptic ulcer disease 8.80 (6.27 vs. 11.39) 17 – AIDS/HIV 2,535.56 (-174.55 vs. 5,245.67)
2 – Congestive heart failure 6.72 (5.53 vs. 7.93) 8 – Peptic ulcer disease 1,409.83 (248.68 vs. 2,570.97)
4 – Cerebrovascular disease 5.14 (3.19 vs. 7.11) 2 – Congestive heart failure 1,079.08 (539.88 vs. 1,618.27)
10 – Diabetes without complications 4.57 (3.32 vs. 5.83) 10 – Diabetes without complications 894.47 (323.60 vs. 1,465.33)
11 – Diabetes with complications 4.04 (2.76 vs. 5.34) 4 – Cerebrovascular disease 758.46 (-150.45 vs. 1,667.37)
14 – Cancer 3.54 (0.37 vs. 6.81) 1 – Myocardial infarction 708.85 (-399.12 vs. 1,816.81)
7 – Connective tissue disease-rheumatic disease 2.41 (0.05 vs. 4.82) 5 – Dementia 622.42 (-2028.19 vs. 3,273.02)
6 – Chronic pulmonary disease 2.03 (0.45 vs. 3.62) 3 – Peripheral vascular disease 509.13 (-152.53 vs. 1,170.79)
1 – Myocardial infarction 1.50 (-0.79 vs. 3.84) 9 – Mild liver disease 411.53 (-253.60 vs. 1,076.65)
Elixhauser comorbidity % Increase in LOS vs. reference Elixhauser comorbidity Increase in Medicare payments vs. reference ($)
18 – Lymphoma 29.38 (18.28 vs. 41.52) 18 – Lymphoma 4,931.55 (-89.18 vs. 9,952.28)
9 – Other neurological disorders 11.62 (9.50 vs. 13.67) 17 – AIDS/HIV 2,334.96 (-380.87 vs. 5050.79)
23 – Obesity 7.87 (4.94 vs. 10.89) 23 – Obesity 1,466.01 (95.50 vs. 2,836.52)
16 – Peptic ulcer disease excluding bleeding 6.373 (3.50 vs. 9.33) 28 – Alcohol abuse 1,341.92 (-875.70 vs. 3,559.54)
4 – Pulmonary circulation disorders 5.22 (1.89 vs. 8.65) 16 – Peptic ulcer disease excluding bleeding 1,273.57 (-74.60 vs. 2,621.74)
13 – Hypothyroidism 5.15 (3.31 vs. 7.032) 13 – Hypothyroidism 1,081.13 (232.70 vs. 1,929.55)
1 – Congestive heart failure 5.05 (3.84 vs. 6.28) 1 – Congestive heart failure 819.58 (261.59 vs. 1,377.57)
12 – Diabetes complicated 4.14 (2.84 vs. 5.46) 4 – Pulmonary circulation disorders 787.17 (-776.44 vs. 2,350.78)
28 – Alcohol abuse 4.06 (-0.56 vs. 8.91) 25 – Fluid and electrolyte disorders 740.21 (263.00 vs. 1,217.41)
25 – Fluid and electrolyte disorders 3.34 (2.30 vs. 4.40) 11 – Diabetes uncomplicated 711.12 (130.67 vs. 1,291.57)